$74.33 0.6%
HSIC Stock Price vs. AI Score (Last 150 days)
Data gathered: May 17

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Henry Schein

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services.


Henry Schein
Price $74.33
Target Price Sign up
Volume 691,720
Market Cap $9.57B
Year Range $61.89 - $80.57
Dividend Yield 0%
PE Ratio 25.16
Revenue per Employee $561,273
Industry Health Care Services

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '243.14B3.02B1.01B93M216M1.100
Q4 '232.99B2.99B925M18M106M0.660
Q3 '233.14B2.96B995M137M260M1.320
Q2 '233.08B2.9B975M140M249M1.310
Q1 '233.05B2.89B966M121M218M1.210

Insider Transactions View All

Connett Bradford C filed to sell 73,108 shares at $74.3.
March 21 '24
BRESLAWSKI JAMES P filed to sell 209,562 shares at $74.4.
March 19 '24
LASKAWY PHILIP A filed to sell 24,565 shares at $76.3.
March 6 '24
BRESLAWSKI JAMES P filed to sell 212,469 shares at $76.5.
March 5 '24
KUEHN KURT P filed to sell 13,598 shares at $77.1.
March 5 '24

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
May 6, 24 Buy $1K - $15K
Michael McCaul
Republican
Feb 22, 24 Sell $1K - $15K
Michael McCaul
Republican
Feb 22, 24 Sell $1K - $15K

What is the Market Cap of Henry Schein?

The Market Cap of Henry Schein is $9.57B.

What is Henry Schein's PE Ratio?

As of today, Henry Schein's PE (Price to Earnings) ratio is 25.16.

How Many People Work at Henry Schein?

As of our latest update, Henry Schein employed approximately 22,000 people worldwide. However, it's important to note that Henry Schein's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Henry Schein's revenue per employee?

$561,273. To calculate Henry Schein's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Henry Schein?

Currently, the price of one share of Henry Schein stock is $74.33.

How can I analyze the HSIC stock price chart for investment decisions?

The HSIC stock price chart above provides a comprehensive visual representation of Henry Schein's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Henry Schein shares. Our platform offers an up-to-date HSIC stock price chart, along with technical data analysis and alternative data insights.

Does HSIC offer dividends to its shareholders?

As of our latest update, Henry Schein (HSIC) does not offer dividends to its shareholders. Investors interested in Henry Schein should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Henry Schein?

Some of the similar stocks of Henry Schein are Abbott Laboratories, HCA Healthcare, Cardinal Health, Idexx Laboratories, and LabCorp.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.